Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis
10.18632/oncotarget.20185
Saved in:
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Impact Journals LLC
2020
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/179755 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-179755 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1797552024-11-11T23:28:36Z Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis Ridouane, Y Lopes, G Ku, G Masud, H Haaland, B DUKE-NUS MEDICAL SCHOOL bevacizumab cetuximab fluorouracil folinic acid irinotecan oxaliplatin panitumumab advanced cancer Article Bayesian learning cancer survival clinical decision making colorectal cancer drug efficacy drug safety human mutational analysis overall survival probability progression free survival systematic review 10.18632/oncotarget.20185 Oncotarget 8 39 66458-66466 2020-10-26T02:57:03Z 2020-10-26T02:57:03Z 2017 Article Ridouane, Y, Lopes, G, Ku, G, Masud, H, Haaland, B (2017). Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis. Oncotarget 8 (39) : 66458-66466. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.20185 1949-2553 https://scholarbank.nus.edu.sg/handle/10635/179755 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Impact Journals LLC Unpaywall 20201031 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
bevacizumab cetuximab fluorouracil folinic acid irinotecan oxaliplatin panitumumab advanced cancer Article Bayesian learning cancer survival clinical decision making colorectal cancer drug efficacy drug safety human mutational analysis overall survival probability progression free survival systematic review |
| spellingShingle |
bevacizumab cetuximab fluorouracil folinic acid irinotecan oxaliplatin panitumumab advanced cancer Article Bayesian learning cancer survival clinical decision making colorectal cancer drug efficacy drug safety human mutational analysis overall survival probability progression free survival systematic review Ridouane, Y Lopes, G Ku, G Masud, H Haaland, B Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| description |
10.18632/oncotarget.20185 |
| author2 |
DUKE-NUS MEDICAL SCHOOL |
| author_facet |
DUKE-NUS MEDICAL SCHOOL Ridouane, Y Lopes, G Ku, G Masud, H Haaland, B |
| format |
Article |
| author |
Ridouane, Y Lopes, G Ku, G Masud, H Haaland, B |
| author_sort |
Ridouane, Y |
| title |
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| title_short |
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| title_full |
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| title_fullStr |
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| title_full_unstemmed |
Targeted first-line therapies for advanced colorectal cancer: A Bayesian meta-analysis |
| title_sort |
targeted first-line therapies for advanced colorectal cancer: a bayesian meta-analysis |
| publisher |
Impact Journals LLC |
| publishDate |
2020 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/179755 |
| _version_ |
1821206524973809664 |